Drug Trial Radar · NCT06189209
Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)
Last checked: Nov 19, 2026Latest source record: Dec 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Mar 4, 2024
Primary completion
Dec 31, 2026
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Rhizen Pharmaceuticals SAIndustry
- Sponsor type
- Industry
- Collaborators
- Incozen Therapeutics Pvt Ltd
- First posted
- Jan 3, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase II, open-label, single-arm, study, designed to evaluate the efficacy and safety of tenalisib in patients with metastatic TNBC, who have received at least one but not more than 3 prior therapies in a metastatic setting.
Conditions
- Triple Negative Breast Cancer (TNBC)
Interventions
TenalisibDrug
Tenalisib will be administered 800mg/ 400mg BID, orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Benefit Rate (CBR)Time frame: 1 year
- Duration of Clinical Benefit (DoCB)Time frame: 1 year
- Overall Response Rate (ORR)Time frame: 1 year
- Progression Free Survival (PFS)Time frame: 1 year
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
HCG City Cancer Center
Vijayawada, Andhra Pradesh, India · Recruiting
Narayana Hrudayala Majumdar Shaw Hospital
Bangalore, Karnataka, India · Recruiting
Tata Memorial Centre
Mumbai, Maharashtra, India · Recruiting
Mumbai Oncocare Centre
Mumbai, Maharashtra, India · Recruiting
Sahyadri Super Speciality Hospital
Pune, Maharashtra, India · Recruiting
Nobel Hospital
Pune, Maharashtra, India · Recruiting
Meenakshi Mission Hospital & Research Center
Madurai, Tamil Nadu, India · Not yet recruiting
Nizams Institute of Medical Science
Hyderabad, Telangana, India · Not yet recruiting
Health Point Hospital
Kolkata, West Bengal, India · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.